AI Article Synopsis
- Acute respiratory distress syndrome (ARDS) is a severe condition affecting newborns and is a leading cause of death and disability in that population.
- Its development is complex, often linked to insufficient pulmonary surfactant due to various health issues, making it hard to differentiate from other diseases.
- Current management lacks a specific treatment, focusing instead on respiratory support, surfactant replacement, ECMO, nutritional support, and fluid management strategies.
Article Abstract
Acute respiratory distress syndrome (ARDS) is a common clinical critical disease and is one of the main causes of death and disability in neonates. The etiology and pathogenesis of neonatal ARDS are complicated. It is an acute pulmonary inflammatory disease caused by the lack of pulmonary surfactant (PS) related to various pathological factors. It is difficult to distinguish neonatal ARDS from other diseases. At present, there is no specific treatment method for this disease. Respiratory support, PS replacement, extracorporeal membrane oxygenation, nutrition support and liquid management are main treatment strategies. This paper reviews the research advance in etiology, clinical characteristics, diagnosis and treatment strategies of neonatal ARDS.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389165 | PMC |
| http://dx.doi.org/10.7499/j.issn.1008-8830.2018.09.006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!